MicroRNAs (miRNAs) are confirmed to be tumor promoters or suppressors in multiple squamous cell carcinomas (SCCs). miR-99a-5p has been demonstrated to be downregulated in cancerous tissues, but its functional role in head and neck SCC (HNSCC) and its mechanism of action have not been fully elucidated. Here, we studied the expression of miR-99a-5p in HNSCC and performed a clinical value assessment and then extracted mature expression data from The Cancer Genome Atlas (TCGA) and microarrays from Gene Expression Omnibus (GEO). Furthermore, biological analysis was constructed via online prediction tools. The results revealed that miR-99a-5p expression was markedly lower in HNSCC tissues than in normal tissues, which also showed significance in the prognosis of HNSCC. However, its diagnostic value could not be verified due to the lack of body fluid samples. Additionally, miR-99a-5p was expressed at higher levels in patients with low histological grade neoplasms than those with high histological grade neoplasms. The age of the patient might also be a possible clinical parameter affecting miR-99a-5p expression. Furthermore, miR-99a-5p significantly influenced HNSCC progression by regulating the PI3K-Akt signaling pathway, in which the key target genes were upregulated in 519 HNSCC tissues compared to 44 normal tissues, as determined by the Gene Expression Profiling Interactive Analysis (GEPIA). In conclusion, our study may provide insights into the expression and mechanism of miR-99a-5p in HNSCC. Further studies are required to elucidate the role of miR-99a-5p and its potential clinical applications for HNSCC.
Squamous cell carcinomas (SCCs), also known as epidermoid carcinomas, are cancers that derived from squamous epithelial cells, which occur in the head and neck, thyroid, esophagus, lung, penis, prostate, bladder, vagina, and cervix [1-9]. Of these, head and neck SCC (HNSCC) has attracted the attention of researchers due to its significant etiology including tobacco [10] , alcohol [11] , and human papilloma virus infection [12] associated with people's lifestyles. HNSCCs, the most frequent head and neck neoplasms, are originating from squamous cells in the nasal and oral cavity, paranasal sinuses, pharynx, larynx, and salivary glands. Men are at a higher risk of HNSCC than women. In particular, cancers of the oral cavity and pharynx were reported to cause 49 670 new cases and 9700 deaths worldwide in 2017 and were the ninth highest cause of new cancer cases in men.
A deeper understanding of HNSCC is accompanied with some remarkable explorations for diagnosis, prognosis, and potential pathogenesis [1, [13] [14] [15] [16] [17] . Current treatment trends include targeted therapy combined with essential chemotherapy, radiotherapy, or immunotherapy [18] [19] [20] [21] [22] [23] . Despite this progress, the increasing morbidity, mortality, and complex pathological changes of HNSCC urgently necessitate more effective means for its diagnosis and treatment, especially targeted treatments based on the further exploration of novel biomarkers.
MicroRNAs (miRNAs) are small noncoding RNAs with 21-25 nucleotides, which have been confirmed to be involved in the initiation and development of multiple SCCs [24] [25] [26] [27] [28] [29] . Studies have shown significantly aberrant expression of several miRNAs in HNSCCs [27, [30] [31] [32] [33] , indicating that miRNA expression levels may be valuable for the clinical diagnosis and prognosis of HNSCC. There is a strong need to characterize the clinical application of miRNAs for HNSCC. Among validated miRNAs, miR-99a-5p, the major member of miR-99a family, has been demonstrated to be associated with carcinogenesis and deterioration in several cancers such as breast cancer, endometrial carcinoma, osteosarcoma, bladder cancer, lung adenocarcinoma, and hepatocellular carcinoma [34] [35] [36] [37] [38] [39] . Several genes have been found to be regulated by miR-99a-5p, which is also enriched in relevant biological pathways [35, [40] [41] [42] [43] [44] [45] .
In HNSCCs, miR-99a-5p has been reported to be downregulated in cancerous tissues [46, 47] . Nevertheless, its functional role and relevant mechanism remain to be fully elucidated. In this study, based on the data acquired from Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and relevant literature, and using prediction tools ( Fig. 1 ), we calculated the expression level and clinical value of miR-99a-5p, and performed biological analysis. This study might provide a comprehensive explanation of the clinical value and underlying mechanism of miR-99a-5p in HNSCC, to identify abnormally expressed miRNAs involved in HNSCC. 
Materials and methods

TCGA data in HNSCC patients
Mature expression data of miR-99a-5p in HNSCC and clinical information were obtained from TCGA datasets via UCSC (http://xena.ucsc.edu/; Accession Number: MIMAT0000097). The IIIuminaHiseq platform included 483 HNSCC patients and 44 adjacent noncancerous head and neck tissues, while the IIIuminaGA platform included 36 patients with HNSCC. No further transformation was performed for the expression data. We explored the possible association between miR-99a-5p expression and clinical parameters for HNSCC patients using the two platforms together or the IIIuminaHiseq platform alone, for further comparison of these two approaches. Based on TCGA data, the diagnostic and prognostic significance of miR-99a-5p was evaluated using the receiver operating characteristic (ROC) curve and the Kaplan-Meier curve, respectively.
Microarray data acquisition and extraction
We obtained available miRNA expression profiling of HNSCC from the GEO database (www.ncbi.nlm.nih.gov/ge o/) and ArrayExpress (https://www.ebi.ac.uk/arrayexpress/ ). The search terms were as follows: ('head AND neck' OR 'laryngeal' OR 'salivary gland' OR 'lip' OR 'mouth' OR 'tongue' OR 'nasopharyngeal' OR 'pharyngeal' OR 'OSCC' OR 'oral squamous cell' OR 'laryngeal' OR 'HNSCC') AND ('carcinoma' OR 'tumor' OR 'cancer' OR 'neoplas*' OR 'malignan*'). Microarray datasets were eligible with the entry criteria listed below: (1) Patients in each dataset were diagnosed with HNSCC; (2) both cancerous and noncancerous specimens were included in each dataset with a sample size of no less than three per group; and (3) miR-99a-5p expression data should be provided. Several relevant elements were extracted from the microarray datasets: author, publication year, country, platform, sample size, and miR-99a-5p expression level. Two authors (Yu-ting Chen and Jianni Yao) independently extracted essential information from all selected chips. Conflicting opinions were solved by a discussion.
In addition, we searched the PubMed, Web of Science, Cochrane, Wiley Online Library, Ovid, EMBASE, CNKI, and VIP databases for relevant articles. The following strategy was constructed for searching: (microRNA-99 OR hsamir-99 OR miR-99 OR MIRN99a microRNA OR mi-croRNA-99a OR miR-99a OR hsa-mir-99a OR MIRN99A OR mir-99a) AND ('head AND neck' OR 'laryngeal' OR 'salivary gland' OR 'lip' OR 'mouth' OR 'tongue' OR 'nasopharyngeal' OR 'pharyngeal' OR 'OSCC' OR 'oral squamous cell' OR 'laryngeal' OR 'HNSCC') AND ('carcinoma' OR 'tumor' OR 'cancer' OR 'neoplas*' OR 'malignan*'). Studies that provided case numbers, mean, and standard deviation (SD) were included.
Statistical analysis
Statistical analyses were performed using SPSS 23.0 (IBM, NY, USA) and Stata version 12.0. Scatter diagrams were plotted for each study using GraphPad Prism 7.0. We also used SPSS 23.0 to calculate the mean AE SD for all the studies based on the expression value of miR-99a-5p. Stata version 12.0 was used to perform continuous variable meta-analysis by evaluating the overall SMD and 95% CI. Both fixed-effect and random-effect model were employed, while the heterogeneity was analyzed by chi-square and I 2 tests. Sensitivity analysis was added to explain the heterogeneity. Results were considered statistically significant if the observed SMD with 95%CI did not cross 0. Additionally, we constructed Begg's funnel and Egger's plot to detect publication bias. For diagnostic tests, we used SPSS 23.0 to plot the ROC curve and to calculate the true positive (TP), false positive (FP), false negative (FN), and true negative (TN) for each included study. Then, diagnosis meta-analysis was performed via MetaDisc 1.4. Sensitivity, specificity, positive likelihood ratio (+LR), negative likelihood ratio (ÀLR), and diagnostic odds ratio (OR), as well as the summarized ROC curve (SROC), were chosen to describe the possible diagnostic value of miR-99a-5p for HNSCC. For practical application, we made a conclusion via the overall consideration of our diagnosis test results and the provided body fluid samples.
Bioinformatics analyses
To predict the putative target genes of miR-99a-5p, we acquired candidate genes from GSE85614 (log2FC < 0), TCGA database (log2FC > 1 and P < 0.05). The miRwalk 2.0, which included miRWalk, Targetscan, miRanda, miRDB, miRNAMap, miRBridge, RNA22, miRMap, PITA, RNAhybrid, PicTar, and Microt4, was also applied to selected genes with a computer algorithm. Genes overlapping at least two prediction platforms were selected. Based on the above source, prospective genes were screened through intersection by online tools (http:// bioinformatics.psb.ugent.be/webtools/Venn/). Meanwhile, validated genes from publications were also added. Based on the predicted target genes, we conducted Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using online tools (https://david.ncifcrf.gov/) to determine the underlying mechanism of miR-99a-5p in HNSCC. The STRING database (https://string-db.org/) was also utilized to construct a PPI network for further characterizing the interactions among promising target genes of miR-99a-5p. Furthermore, hub genes with over five degrees were selected. In addition, we acquired differentially expressed genes of HNSCC from the Gene Expression Profiling Interactive Analysis (GEPIA) (|log2FC| > 1.5, P < 0.05) and conducted another KEGG pathway analysis to detect the potential pathways for the progression of HNSCC.
Expression of hub genes and their correlations with miR-99a-5p
Based on GEPIA [48] , we detected the expression of hub genes in HNSCC and normal tissues to further identify the target genes of miR-99a-5p. We also performed Spearman's correlation analysis to explain the correlation between hub genes and miR-99a-5p. Besides, the protein level of those hub genes was acquired from The Human Protein Atlas.
Results
Relationships between miR-99a-5p expression and clinicopathological parameters in HNSCC Statistical analysis based on the IIIuminaHiseq platform (Table 1) revealed that miR-99a-5p was expressed at a lower level in HNSCC tissues than in normal tissues (7.987 AE 1.467 vs 10.348 AE 0.625, respectively; P < 0.001). In addition, miR-99a-5p was expressed at higher levels in G1-G2 than in G3-G4 neoplasms (8.140 AE 1.239 vs 7.968 AE 1.525, respectively, P = 0.001). When statistical analysis was carried out using a combination of the IIIuminaHiseq and IIIumi-naGA platforms (Table 2) , the results revealed that miR-99a-5p was expressed at lower levels in HNSCC tissues than in adjacent normal tissues (8.028 AE 1.498 vs 10.348 AE 0.625, respectively, P < 0.001). Significant differences were also observed among neoplasms of different histological grades (7.841 AE 1.410 vs 8.413 AE 1.622, respectively, P < 0.001). In addition, miR-99a-5p expression was higher in patients over 50 years than in those less than 50 years (8.090 AE 1.453 vs 7.691 AE 1.695, respectively, P = 0.027). As for the diagnostic test based on TCGA, miR-99a-5p might show significant diagnostic value for HNSCC (AUC = 0.934, P < 0.001; AUC = 0.926, P < 0.001; Fig. 2 ). However, the tissue types of patients were unknown. Additionally, survival analysis indicated a probable prognostic value for HNSCC patients (P < 0.01; Fig. 3 ). The added IIIumi-naGA platform did not significantly affect our research; nevertheless, it reminds us of the need for more samples for further exploration of the relationships between miR-99a-5p expression and clinicopathological parameters of HNSCC patients.
Comprehensive meta-analysis based on microarrays
MiR-99a-5p expression level in HNSCC
A total of 18 eligible microarrays were selected from GEO datasets. Finally, 924 HNSCC tissues and 212 noncancerous head and neck tissues were included as GSE34496 and GSE73460 acted equally. However, no publications met our criteria. Then, continuous variable meta-analysis pooled the expression data from 17 microarrays (Table 3) , among which there were 6 significant microarrays (P ≤ 0.05; Fig. 4 ). Other microarrays without statistical significance were displayed in Fig. S1 (A-K). As the overall result revealed, miR-99a-5p expression was lower in HNSCC tissue than in the control group both for fixed-effect (SMD = À0.60, 95% CI = À0.78 to À0.42, I 2 = 87.5%) and random-effect (SMD = À0.54, 95% CI = À1.06 to À0.01, I 2 = 87.5%) models (Fig. 5 ). Sensitivity analysis was then carried out to evaluate the influence of each chip. GSE45238 and GSE32960 might be the sources of heterogeneity (Fig. 6) . Additionally, Begg's funnel and Egger's plot indicated no obvious publication bias (Fig. 7) .
Diagnostic value of miR-99a-5p for HNSCC
ROC curves for all eligible studies were plotted. Four representative ROC curves including GSE31277, GSE32960, GSE36682 and GSE45238 were displayed in Fig. 8 , with P value less than 0.05, while the other studies showing no statistical significance were in Fig. S1 (L-X). Further analysis was performed based on the TP, FP, FN, and TN results ( Table 3) . As shown in Fig. 9 , the SROC curve verified the diagnostic value of miR-99a-5p in HNSCC as the AUC was 0.85 (95% CI = 0.77-0.92), with a sensitivity of 0.56 (95%CI=0.52-0.59, P < 0.001) and a specificity of 0.85 (95% CI = 0.80-0.90, P = 0.030). Furthermore, likelihood ratios were calculated (Pool +LR = 2.90, 95% CI = 1.91-4.39, P = 0.074; pool ÀLR = 0.52, 95% CI = 0.38-0.73, P < 0.001), respectively. The diagnostic OR of 8.23 (95% CI = 3.71-18.25, P = 0.006) also suggested a significant diagnostic value when based on all the included samples. However, only the GSE41268 and GSE69002 chips provided body fluid samples (AUC = 0.333, P = 0.201 and AUC = 0.750, P = 0.197, respectively). Thus, the clinical diagnostic value of miR-99a-5p for HNSCC could not be fully verified.
Bioinformatics analyses of miR-99a-5p and HNSCC
Prediction of miR-99a-5p target genes
We screened 14 174 genes from GSM2279805, 1532 genes from the TCGA dataset, and 3085 genes from miRwalk 2.0 after removing duplicates. As the analytical integration shown, a total of 98 genes overlapped in the GSM microarray and online software (Fig. 10) . MTMR3, IGF1R, MTOR, NOX4, and HOXA1, which were searched from published literature, were also included [49] [50] [51] [52] [53] . Finally, a total of 103 genes were identified as the promising target genes of miR-99a-5p in HNSCC (Table 4) .
GO enrichment and KEGG pathway analysis
For GO enrichment analysis, the results comprised biological process (BP), cellular component (CC), and molecular function (MF). The potential target genes of miR-99a-5p significantly influence 15 GO terms (P < 0.05), including cell migration and phosphatidylinositol-mediated signaling in BP, and focal adhesion in CC. Additionally, KEGG pathway analysis also indicated that the PI3K-Akt signaling pathway and pathways in cancer were the most enriched for miR-99a-5p in HNSCC (P < 0.001, FDR < 0.05; Fig. 11 ). According to another KEGG pathway analysis, the PI3K-Akt signaling pathway and pathways in cancer were also confirmed to be significant in the progression of HNSCC (P < 0.001; Fig. 12 ). 
PPI network construction
The 103 putative target genes were inputted into STRING for constructing a PPI network (Fig. 13 ). There were 103 nodes and 49 edges with an enrichment P value of 0.007. Thus, we further identified PIK3CD, IGF1R, PDGFRB, and MTOR as the hub genes of miR-99a-5p in HNSCC (all degrees > 5).
Expression value of hub genes and their correlations with miR-99a-5p
As shown in the boxplot (Fig. 14) , PIK3CD, IGF1R, PDGFRB, and MTOR all exhibited higher expression levels in 519 HNSCC tissues compared to the 44 normal tissues. PIK3D and IGFR1 expression levels were significant negatively correlated to miR-99a-5p in HNSCC (PIK3D: r = À0.318, P < 0.001; IGFR1: r = À0.118, P = 0.005), while PDGFRB and MTOR were mildly negatively correlated with miR-99a-5p (PDGFRB: r = À0.036, P = 0.393; MTOR: r = À0.012, P = 0.774; Fig. 15 ).
Discussion
There has been a trend of targeted treatment for human cancers in recent years. Illuminated by the abnormal biological signals in cancer cells, people commit to detecting novel biomarkers for exploring the potential mechanism of tumorigenesis and progression as well as further clinical applications such as cancer diagnosis, treatment, and prognosis. Therein, the miRNAs, which appear to be involved in gene regulation, were confirmed to be tumor suppressors or promoters [54, 55] .
Several studies have demonstrated that miR-99a-5p could affect proliferation, migration, and invasion in various cancers, including HNSCCs, via modulating gene expression [36, 56, 57] . The reduced miR-99a-5p expression was confirmed to suppress the insulin-like growth factor mammalian of rapamycin signaling (IGF-mTOR signaling) through binding sites in their 3ʹ-untranslated regions (UTRs) in childhood adrenocortical tumors [58] . According to Kuo et al., miR-99a-5p could inhibited myotubularin-related protein 3 (MTMR3) expression then suppress the metastasis of Table 4 . Validated genes of miR-99a-5p from the GEO, TCGA, and miRwalk databases and literature. MTMR3  IGF1R  MTOR  NOX4  HOXA1  Validated by analytical integration  LAMA5  AGO2  HIP1  SLC44A1  TNFAIP8L1  POLE  RELB  U2SURP  RNF213  DNASE2  MPP3  TRAM2  LHFPL2  NCS1  FAM64A  TTYH3  HSP90B1  GUCY1A3  WNT7B  CELSR1  SLC39A14  MXRA8  NRIP3  PAPLN  ASNS  PIK3CD  NAV1  FANCA  STK10  AFAP1L1  B4GALNT1  TAPBP  WARS  TUSC3  CASK  PRSS23  HENMT1  ACVR1  ANGPT2  BICD1  DLX5  RGS3  ABCG1  ITGA3  SH2B3  COL5A1  CTLA4  ECE1  ETS1  EXT2  FOXM1  BCAM  MN1  PDGFRB  PYCR1  MAPK12  SLC1A4  GPR68  STC2  UBE2L6  SCRN1  IGF2BP2  TSPAN9  SLC2A6  KIAA0930  FLRT2  TMEM184B  DKK3  EPB41L4B  KIRREL  YEATS2  IPO9  FAM111A  STRA6  ORAI2  LBH  APH1B  KRBA1  RNASE7  MARVELD3  C1QTNF1  ANTXR2  GJB4  C10orf35  NPNT  SH3PXD2B  ADAM8  COL6A2  HAS2  ODC1  TGFB3  FADD  DDIT4  MISP  MFAP5  SYT7  ARHGEF39 NRBP2 oral cancer (OC) [49] . As for HNSCC, Chen et al. also reported that IGFR1 and MTOR were repressed by ectopic transfection of miR-99-5p [51] . In addition, Yan et al. suggested that downregulation of miR-99a-5p contributed to oral squamous cell carcinoma (OSCC) by targeting MTOR, further indicating the relation between miR-99a-5p and HNSCC development [59] . Recently, miR-99a-5p was found to facilitate oral tumor cells by targeting NADPH oxidase 4 (NOX4) [52] . To achieve a deeper understanding of the mechanism underlying miR-99a-5p, we identified its potential targets and performed the comprehensive biological pathway analysis. According to our KEGG pathway analysis, miR-99a-5p significantly affected the progression of HNSCC by regulating the PI3K-Akt signaling pathway, of which the predicted target genes, phosphatidylinositol-4,5-bisphosphate 3kinase catalytic subunit data (PIK3CD), insulin-like growth factor 1 receptor (IGFR1), platelet-derived growth factor receptor, beta polypeptide (PDGFRB), and mechanistic target of rapamycin (MTOR) were involved. The PI3K-Akt signaling pathway, concretely explained as the phosphatidylinositol 3-kinase (PI3K)/ AKT/mammalian target of the rapamycin (mTOR) signaling pathway, is aberrant in many types of cancer [60] [61] [62] [63] . The involved PIK3CD, IGFR1, PDGFRB, and MTOR4, also screened out by PPI construction, were further utilized to analyze the correlations with miR-99a-5p. We found that the four hub genes all exhibited higher expression levels in HNSCC tissues than in normal tissues, gaining more possibility to be the target genes of miR-99a-5p. Interestingly, a negative correlation was found between these four genes and miR-99a-5p, with PIK3D and IGFR1 showing significant negative correlation with miR-99a-5p in HNSCC and PDGFRB and MTOR showing a mild negative correlation. Thus, together with the findings of previous researches and our results, we speculated that the dysfunctional PI3K-Akt signaling pathway was implicated in the development of HNSCC. Moreover, it seems that PI3K-Akt signaling pathway was regulated by miR-99a-5p according to the statistical correlation analysis, which further provided evidence for the potential clinical value of miR-99a-5p detection in HNSCC.
Genes
Validated in HNSCC
Statistical analysis of miR-99a-5p expression would confirm our speculation. Previous studies have suggested that repressed miR-99a-5p may contribute to tumorigenesis via being unable to control the target genes. Thus far, no study has specifically analyzed the miR-99a-5p expression level in HNSCC, but several studies have demonstrated the lower expression of miR-99a-5p in HNSCC [46, 51, 59] . According to our GEO meta-analysis and TCGA data mining results, the miR-99a-5p expression level was markedly lower in HNSCC than in normal tissues. In addition, miR-99a-5p expression was higher in low neoplasm histological grades than high histological grades, and the patient's age may also be a possible clinical parameter. Furthermore, we found that miR-99a-5p showed significance in diagnostic and prognostic tests; however, due to limited body fluid samples, the results could not be used as representative and its diagnostic applicability in the clinical setting could not be determined. Thus, additional studies are needed to demonstrate the clinical role of miR-99a-5p in the diagnosis and prognosis of HNSCC.
This study has some limitations. First, the different miRNA extraction methods may disturb the results of our meta-analysis. Second, the HNSCC and corresponding samples were mostly derived from tissue sections, lead to an unverified diagnostic value. Third, although we utilized TCGA data to expand our data, the big gap between the quantity of cancerous and noncancerous tissues brought down the reliability. And fourth, the resource of online protein databases and relevant immunohistochemical staining samples were limited so that we could not further validate the function of miR-99a-5p via the protein level of hub genes. Despite these limitations, based on our metaanalysis, the results suggest that miR-99a-5p expression was significantly lower in HNSCC than in normal tissue. Biological analysis also suggested that miR-99a-5p may participate in HNSCC by suppressing the hub genes, PIK3CD, IGFR1, PNGFRB, and MTOR.
In general, our study confirmed that miR-99a-5p might be a tumor suppressor in HNSCC with downregulated expression in HNSCC tissues, via the PI3K-Akt signaling pathway. Further studies are required to elucidate the role of miR-99a-5p in diagnosis and prognosis for HNSCC and provide the basis for that miR-99a-5p execute its function via the protein level of the targets, especially those hub genes predicted by our research. 
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Additional Supporting Information may be found online in the supporting information section at the end of the article: Fig. S1 . (A-K): Scatter plots of miR-99a-5p expression data in normal and HNSCC tissues in the other 11 microarrays without statistical significance. (L-X): ROC curves of the other 13 microarrays without statistical significance.
